Nevro (NVRO) announced that it has received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system. The CE marking allows Nevro to market HFX iQ in all countries that recognize this certification.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NVRO:
- Nevro price target raised to $6 from $5 at Baird
- Nevro price target lowered to $7 from $8 at Canaccord
- Nevro price target lowered to $6 from $7 at Piper Sandler
- Nevro Corp. Shows Resilience Amidst Revenue Challenges
- Nevro lowers 2024 revenue view to $400M-$405M from $435M-$445M
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
